Despite the prognostic value of PD-L1 expression, the immunological pathway with high expressions of PD-L1 in ovarian cancer is rarely studied and the molecular mechanism that includes immune cells and tumor cells remain elusive [10]. The gene discussed is CD274; the disease is ovarian carcinoma.